| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 1 |
| 1 | ADALIMUMAB-AATY | 1 |
| 2 | ADALIMUMAB-ADAZ | 1 |
| 3 | ADALIMUMAB-FKJP | 1 |
| 4 | CERTOLIZUMAB PEGOL | 1 |
| 5 | CIMETIDINE | 1 |
| 6 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 |
| 7 | ESOMEPRAZOLE MAGNESIUM | 1 |
| 8 | FLUOXETINE HYDROCHLORIDE | 1 |
| 9 | GOLIMUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 1 | CIMETIDINE | 1 | 0.0001 |
| 2 | GOLIMUMAB | 1 | 0.0001 |
| 3 | PANCRELIPASE | 1 | 0.0000 |
| 4 | ADALIMUMAB-FKJP | 1 | 0.0000 |
| 5 | ADALIMUMAB-AATY | 1 | 0.0000 |
| 6 | ADALIMUMAB-ADAZ | 1 | 0.0000 |
| 7 | VEDOLIZUMAB | 1 | 0.0000 |
| 8 | USTEKINUMAB | 1 | 0.0000 |
| 9 | FLUOXETINE HYDROCHLORIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Histamine-2 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |